Behavioural Activation Therapy: Clinical Trials

1 trial of Behavioural Activation Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Behavioural Activation Therapy: new trials by email Literature Review of Behavioural Activation Therapy trials Research Report on Behavioural Activation Therapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression
Ketamine (0.5 mg/kg), Behavioural Activation Therapy - Treatment Resistant Depression, Major Depressive Disorder (MDD)
Phase 2 / Phase 3Not yet recruitingThe Royal's Institute of Mental Health Research602026-09-012026-09-03

Conditions studied

Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)

Sponsors

The Royal's Institute of Mental Health Research (1)

Countries

Canada (1)

Top investigators

Jeanne Talbot, MD, PhD (1)  ·  Jennifer Phillips, PhD (1)